Patients using tirzepatide for diabetes and obesity show a reduced risk of developing proliferative diabetic retinopathy and macular edema. Tirzepatide use is associated with a lower risk of incident ...

Tirzepatide was also linked to fewer complications, including those requiring interventions, compared with lifestyle intervention alone. HealthDay News — For patients with diabetes and overweight or ...

Tirzepatide use was associated with a reduced 12-month risk for diabetic retinopathy incidence and worsening events vs lifestyle intervention alone. HealthDay News — For patients with diabetes and ...

In advanced stages of diabetic retinopathy (DR), vitreoretinal surgery (most often vitrectomy with or without intraocular tamponades) can be used to clear blood or scar tissue from the retina or ...

Individuals with type 2 diabetes — with or without retinopathy — had higher risks for incident Alzheimer’s disease and dementia than those without the blood sugar disorder. Among patients with ...

GA, UNITED STATES, February 14, 2026 /EINPresswire.com/ — Diabetic retinopathy remains a leading cause of preventable vision loss, yet predicting which patients ...

Diabetic retinopathy develops through complex microvascular damage driven by chronic hyperglycemia, yet traditional risk factors such as disease duration or glycemic control explain only part of ...

Diabetic retinopathy remains a leading cause of preventable vision loss, yet predicting which patients will experience disease progression remains challenging. This study demonstrates that subtle ...

Patients at risk for diabetic retinopathy who have Black or Hispanic ethnicities may require targeted interventions to monitor for early signs of disease. Individuals who are Black or Hispanic are at ...